Evidence map›Paper›PMID 37658224›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2024

Management of patients with chronic rhinosinusitis with nasal polyps in Spain: learnings from a nationwide survey of otorhinolaryngologists.

Isam Alobid, Rafael Fernández Liesa, Jose Miguel Villacampa Aubá, Abraham L Moure, M Guadalupe Sánchez-Herrero, Alfonso Del Cuvillo Bernal

Open access · hybridAbstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Isam AlobidRhinology and Skull Base Unit, ENT Department, Hospital Clinic, University of Barcelona, Barcelona, Spain. isamalobid@gmail.com.ORCID http://orcid.org/0000-0001-7204-5599
Rafael Fernández LiesaRhinology and Anterior Skull Base Unit, ENT Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.ORCID http://orcid.org/0000-0002-9678-1897
Jose Miguel Villacampa AubáENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz, University Hospital, Madrid, Spain.ORCID http://orcid.org/0000-0002-1321-007X
Abraham L MoureSpecialty Care Medical Department, GSK, Madrid, Spain.ORCID http://orcid.org/0000-0003-0255-1036
M Guadalupe Sánchez-HerreroSpecialty Care Medical Department, GSK, Madrid, Spain.ORCID http://orcid.org/0000-0003-4352-3509
Alfonso Del Cuvillo BernalRhinology and Asthma Unit, ENT Department, University Hospital of Jerez, Jerez de La Frontera, Cadiz, Spain.ORCID http://orcid.org/0000-0003-4332-0920
GlaxoSmithKline (Spain) · ESBarcelona Institute for Global Health · ESHospital Jerez Puerta del Sur · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Miguel Servet · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe the self-reported practices on the diagnosis, treatment, and follow-up of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) by ear, nose, and throat (ENT) specialists in Spain to identify potential areas for management optimization.

methodsA cross-sectional online survey with 16 questions was carried out. Recruitment was performed by emailing registered ENT specialists in the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC).

resultsIn total, 127 ENT specialists completed the survey. Fifty-one percent of respondents combined clinical criteria and objective evidence of mucosal inflammation to diagnose CRSwNP. Patient interview and, to a lower degree, a visual analogue scale were the most employed diagnostic tools to quantify symptom severity. Less than half (45%) routinely used the 22-item sino-nasal outcomes test (SNOT-22) to assess the impact of CRSwNP disease in quality of life. The use of patient-reported outcomes and other clinical evaluation tools showed a larger uptake among ENT specialists that worked at an ENT department with an available rhinology unit. Almost all the specialists surveyed (95%) recommended biological treatment, particularly in patients with uncontrolled CRSwNP with respiratory comorbidities (76%), as well as in candidates for revision surgery (66%).

conclusionSpanish otorhinolaryngologists showed a trend toward incorporating CRSwNP guideline recommendations in their clinical practice. The observed low uptake of patient-reported outcomes and objective clinical evaluation tools in routine clinical practise have been identified as areas for optimizing the management of patients with CRSwNP.

Indexed as

Nasal PolypsRhinitisRhinosinusitisSinusitisChronic DiseaseCross-Sectional StudiesHumansQuality of LifeSpainSurveys and QuestionnairesBiological therapyInflammationNasal polypsNose diseasesPatient reported outcome measuresSurveys and Questionnaires

Identifiers

PMID37658224
PMCPMC10764407
OpenAlexW4386386414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.